Global CRO footprint SanaClis operates as a full-service or functional CRO with in-house clinical supply chain, logistics, and sourcing, serving Europe, the USA, Asia and Central/Eastern Europe. This presents a sales opportunity to offer expanded regional support, bi-directional transfer of trials, and supply chain resilience for sponsors pursuing global studies.

End-to-end supply Privately owned GMP- and GDP-certified depots worldwide enable ambient and cold-chain storage, packaging, labeling, and distribution for IMPs. Pitch added value around secure, compliant distribution, accelerated site activation, and reduced risk of supply interruptions for multicenter trials.

Therapeutic breadth Capabilities span all therapeutic areas with services from project management and regulatory affairs to pharmacovigilance and biostatistics, plus in-house QP release and ancillaries sourcing. Opportunity to upsell integrated trial services or specialized packaging and labeling for complex study designs.

Operational rigor Track record delivering for virtual biotech to top 10 pharma, emphasizing quality and predictable delivery. Use this position to engage sponsors seeking reliability, scalable resourcing, and transparent performance metrics for outsourced trials.

Sustainability edge EcoVadis Silver Medal and sustainability focus provide a differentiator for sponsors prioritizing ESG in CRO selection. Leverage to pursue green supply chain opportunities, sustainability-linked contracts, and differentiated vendor risk assessments.